Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

362 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS).
Boonen S, Pye SR, O'Neill TW, Szulc P, Gielen E, Borghs H, Verschueren S, Claessens F, Adams JE, Ward KA, Bartfai G, Casanueva F, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Tajar A, Wu FC, Vanderschueren D; EMAS Group. Boonen S, et al. Among authors: vanderschueren d. Eur J Endocrinol. 2011 Dec;165(6):977-86. doi: 10.1530/EJE-11-0353. Epub 2011 Sep 8. Eur J Endocrinol. 2011. PMID: 21903895 Clinical Trial.
No longer to be ignored: Hypophosphatemia following intravenous iron administration.
Strubbe M, David K, Peene B, Eeckhout B, Van der Schueren B, Decallonne B, Vangoitsenhoven R, Vanderschueren D, Antonio L. Strubbe M, et al. Among authors: vanderschueren d. Rev Endocr Metab Disord. 2024 Dec 9. doi: 10.1007/s11154-024-09926-5. Online ahead of print. Rev Endocr Metab Disord. 2024. PMID: 39648248 Review.
Sociodemographic, lifestyle, and medical factors associated with calculated free testosterone concentrations in men: individual participant data meta-analyses.
Narinx N, Marriott RJ, Murray K, Adams RJ, Ballantyne CM, Bauer DC, Bhasin S, Biggs ML, Cawthon PM, Couper DJ, Dobs AS, Flicker L, Hankey GJ, Hannemann A, Wilkening R, Martin SA, Matsumoto AM, Ohlsson C, O'Neill TW, Orwoll ES, Shores MM, Steveling A, Travison TG, Wittert GA, Wu FCW, Antonio L, Vanderschueren D, Yeap BB. Narinx N, et al. Among authors: vanderschueren d. Eur J Endocrinol. 2024 Oct 29;191(5):523-534. doi: 10.1093/ejendo/lvae133. Eur J Endocrinol. 2024. PMID: 39575586
Use of calculated free testosterone in men: advantages and limitations.
Nyamaah JA, Narinx N, Antonio L, Vanderschueren D. Nyamaah JA, et al. Among authors: vanderschueren d. Curr Opin Endocrinol Diabetes Obes. 2024 Dec 1;31(6):230-235. doi: 10.1097/MED.0000000000000891. Epub 2024 Oct 9. Curr Opin Endocrinol Diabetes Obes. 2024. PMID: 39445719 Review.
High-dose vitamin D supplementation does not improve outcome in a cutaneous melanoma population: results of a randomized double-blind placebo-controlled study (ViDMe trial).
De Smedt J, Van Kelst S, Janssen L, Marasigan V, Boecxstaens V, Bogaerts K, Belmans A, Vanderschueren D, Vandenberghe K, Bechter O, Aura C, Lambrechts D, Strobbe T, Emri G, Nikkels A, Garmyn M. De Smedt J, et al. Among authors: vanderschueren d. Br J Dermatol. 2024 Nov 18;191(6):886-896. doi: 10.1093/bjd/ljae257. Br J Dermatol. 2024. PMID: 38913652 Clinical Trial.
362 results